This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Management

Authoring team

The two complications of WPW are the development of an AV re-entrant tachycardia or atrial fibrillation.

An AV re-entrant tachycardia is managed as for any other supraventricular tachycardia (see linked item).

Atrial fibrillation secondary to WPW should not be treated with AV-blocking drugs such as verapamil and digoxin. The simplest method of terminating atrial fibrillation is cardioversion. If drugs are to be used then they must slow conduction in the accessory pathway e.g. intravenous sotalol, flecainide, amiodarone. These drugs will slow the ventricular response and will often result in restoration of sinus rhythm.

For prevention of atrial fibrillation drugs such as oral sotalol and amiodarone are effective.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.